Enzon Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 73   

Articles published

ENZN 0.963 -0.037 (-3.69%)
price chart
Enzon Pharmaceuticals Inc (ENZN): Warning! Enzon Pharmaceuticals Is ...
Finance profile for the company! Right off the bat, that doesn't give us a lot of confidence, now does it? Enzon Pharmaceuticals (NASDAQ:ENZN) used to be a research stage biotech firm, focusing on a technology known as PEGylation. PEGylation was used ...
Enzon Pharmaceuticals Inc Stock Upgraded (ENZN)
This is a signal of significant strength within the corporation. Compared to other companies in the Biotechnology industry and the overall market, ENZON PHARMACEUTICALS INC's return on equity significantly exceeds that of both the industry average and ...
Enzon Pharmaceuticals, Inc. (ENZN): Are Hedge Funds Right About This Stock?
Is Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) a buy, sell, or hold? The best stock pickers are taking a bearish view.
Enzon Pharmaceuticals sells Indy drug plant; 100 local jobs safe
Orphan drugs, as they're known in the pharmaceutical industry, treat diseases that afflict fewer than 200,000 patients in the United States.
Related articles »  
Receptos Inc, Enzon Pharmaceuticals Inc Soar Midday
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) jumped +18.21% and continues on what has been a solid month-long run, its price up +21.73% since May 12th. Carl Icahn has maintained a 5.9-million-share position in the biotech firm across several quarters.
Enzon Pharmaceuticals, Inc. (ENZN): Insiders Aren't Crazy About It
Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) was in 15 hedge funds' portfolio at the end of the first quarter of 2013.
Enzon Pharmaceuticals Inc (ENZN) Plans Special Dividend of $0.10
Enzon Pharmaceuticals logo Enzon Pharmaceuticals (NASDAQ:ENZN) declared a special dividend on Tuesday, December 9th, Analyst Ratings Net reports.
Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes ...
On Friday, shares in Enzon Pharmaceuticals Inc. fluctuated between $1.08 and $1.29 before ending the session 14.29% lower at $1.08.
Related articles »  
Enzon Pharmaceuticals Inc Short Interest Update
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) has seen some short covering recently. Short interest has registered a change of -36.61% in the past 1 month.
Wednesday Stocks: Enzon Pharmaceuticals Inc. (ENZN), Comstock Holding ...
Enzon Pharmaceuticals Inc. (ENZN) closed the session yesterday at $0.99, a gain of 2.05% trading at a volume of 38797 shares.